Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 19, 2024

BUY
$6.52 - $12.01 $119,967 - $220,984
18,400 New
18,400 $182,000
Q4 2023

Feb 14, 2024

BUY
$6.52 - $12.01 $119,967 - $220,984
18,400 New
18,400 $182,000
Q1 2022

May 16, 2022

SELL
$7.01 - $10.94 $80,993 - $126,400
-11,554 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$9.56 - $17.3 $110,456 - $199,884
11,554 New
11,554 $149,000

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $359M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Old Well Partners, LLC Portfolio

Follow Old Well Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Well Partners, LLC with notifications on news.